Consulting company Rare. has opened its Healthcare Insights library to free access.
The platform is divided into three categories; Market Insights, Market Stats and Brand Amplification. Market Insights features articles exploring key specialty developments using data and analysis. One article examines the recent acquisition of Obagi Medical by Bridgepoint, and questions whether an injectable-led strategy is the right approach for the UK market, drawing on clinic data that suggests a stronger cross-sell relationship with energy-based devices than injectables.
Market Stats presents findings from Rare.’s specialty audits. In April 2026, the company audited 24,937 UK medical aesthetics clinics and found that injectable treatments continue to dominate the sector. According to the data, 85.5% of clinics offer botulinum toxin treatments, 70.9% offer dermal fillers and 55.7% offer skin boosters.
Brand Amplification focuses on brand visibility and market presence. Recent reports include an analysis of the UK hyaluronic acid dermal filler market, which identified Juvéderm as the most-mentioned brand among clinics, followed by Restylane and Teosyal.